BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 11804319)

  • 21. Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors.
    Hosoya K; Kisseberth WC; Alvarez FJ; Lara-Garcia A; Beamer G; Stromberg PC; Couto CG
    J Am Anim Hosp Assoc; 2009; 45(1):14-8. PubMed ID: 19122059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection.
    Murphy S; Sparkes AH; Smith KC; Blunden AS; Brearley MJ
    Vet Rec; 2004 Jun; 154(24):743-6. PubMed ID: 15224593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mast cell tumors in dogs--diagnosis and therapy of a malignant skin tumor].
    Kessler M
    Tierarztl Prax; 1995 Apr; 23(2):172-8. PubMed ID: 7624860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999).
    Séguin B; Leibman NF; Bregazzi VS; Ogilvie GK; Powers BE; Dernell WS; Fettman MJ; Withrow SJ
    J Am Vet Med Assoc; 2001 Apr; 218(7):1120-3. PubMed ID: 11318363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001).
    Sfiligoi G; Rassnick KM; Scarlett JM; Northrup NC; Gieger TL
    J Am Vet Med Assoc; 2005 Apr; 226(8):1368-74. PubMed ID: 15844431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additional local therapy with primary re-excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs.
    Kry KL; Boston SE
    Vet Surg; 2014 Feb; 43(2):182-9. PubMed ID: 24392683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors.
    Jaffe MH; Hosgood G; Taylor HW; Kerwin SC; Hedlund CS; Lopez MK; Davidson JR; Miller DM; Paranjpe M
    Vet Pathol; 2000 Jan; 37(1):40-6. PubMed ID: 10643979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006).
    Stefanello D; Morello E; Roccabianca P; Iussich S; Nassuato C; Martano M; Squassino C; Avallone G; Romussi S; Buracco P
    Vet Surg; 2008 Jul; 37(5):461-5. PubMed ID: 18986313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
    Abadie JJ; Amardeilh MA; Delverdier ME
    J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mast cell tumor destruction by deionized water.
    Grier RL; Di Guardo G; Schaffer CB; Pedrosa B; Myers R; Merkley DF; Thouvenelle M
    Am J Vet Res; 1990 Jul; 51(7):1116-20. PubMed ID: 2117868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008-2012).
    Pratschke KM; Atherton MJ; Sillito JA; Lamm CG
    J Am Vet Med Assoc; 2013 Nov; 243(10):1436-41. PubMed ID: 24171373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal mast cell tumor in the dog: A case series.
    Khoo A; Lane A; Wyatt K
    Can Vet J; 2017 Aug; 58(8):851-854. PubMed ID: 28761193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence rates and clinical outcome for dogs with grade II mast cell tumours with a low AgNOR count and Ki67 index treated with surgery alone.
    Smith J; Kiupel M; Farrelly J; Cohen R; Olmsted G; Kirpensteijn J; Brocks B; Post G
    Vet Comp Oncol; 2017 Mar; 15(1):36-45. PubMed ID: 25643820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993).
    Frimberger AE; Moore AS; LaRue SM; Gliatto JM; Bengtson AE
    J Am Anim Hosp Assoc; 1997; 33(4):320-4. PubMed ID: 9204467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [General facts on mastocytoma in the dog. Apropos of the first Tunisian case].
    Zarrouk K; Chadli A; Fontaine M; Ben Zina F
    Arch Inst Pasteur Tunis; 1979 Sep; 56(3):255-78. PubMed ID: 122139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs.
    Patnaik AK; Ehler WJ; MacEwen EG
    Vet Pathol; 1984 Sep; 21(5):469-74. PubMed ID: 6435301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of surgical margins utilized for removal of cutaneous mast cell tumors in dogs.
    Selmic LE; Ruple A
    BMC Vet Res; 2020 Jan; 16(1):5. PubMed ID: 31906934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors.
    Davies DR; Wyatt KM; Jardine JE; Robertson ID; Irwin PJ
    J Am Anim Hosp Assoc; 2004; 40(2):124-30. PubMed ID: 15007048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soft tissue sarcomas and mast cell tumours in dogs; clinical behaviour and response to surgery.
    Baker-Gabb M; Hunt GB; France MP
    Aust Vet J; 2003 Dec; 81(12):732-8. PubMed ID: 15080482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs.
    Turrel JM; Kitchell BE; Miller LM; Théon A
    J Am Vet Med Assoc; 1988 Oct; 193(8):936-40. PubMed ID: 3142828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.